October
25
 

Financial links to drug use guidelines

Many of the researchers and doctors who write the rules on prescribing drugs have financial connections to the manufacturers, according to an investigation by the leading journal Nature. More than one-third of authors declared that they had financial links to drug companies and more than 70% of clinical panels are affected. In one case, every member of a panel writing the guidelines for a treatment for anaemia for HIV patients had been paid by the drug's manufacturer. "The practice stinks," says Drummond Rennie, deputy editor of the Journal of the American Medical Association.

Although such links have been strongly criticised, the bodies which produce the guidelines counter that there simply aren't enough experts without potential conflicts of interest. The American Diabetes Association estimates that three-quarters of the members eligible to write clinical guidelines have conflicts of interest.


comments powered by Disqus
 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Many Dutch doctors open to euthanasia for existential suffering
21 Feb 2015
Colombia may finally legalise euthanasia
21 Feb 2015
Professionalise surrogacy, say New Zealand academics
21 Feb 2015
Paternity presumption threatens same-sex marriage
21 Feb 2015
Disgraced researcher Hwang Woo-suk teams up with US scientist
21 Feb 2015